0001600132-18-000177.txt : 20181123 0001600132-18-000177.hdr.sgml : 20181123 20181123162348 ACCESSION NUMBER: 0001600132-18-000177 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181120 FILED AS OF DATE: 20181123 DATE AS OF CHANGE: 20181123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dekker Martin CENTRAL INDEX KEY: 0001643049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 181199728 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 STREET 2: PERRYVILLE III CORPORATE PARK CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_154300821209542.xml FORM 4 X0306 4 2018-11-20 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001643049 Dekker Martin C/O BELLEROPHON THERAPEUTICS, INC. 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 0 1 0 0 VP of Engineering & Manuf Stock Option (right to buy) 0.91 2018-11-20 4 A 0 137500 0 A 2028-11-20 Common Stock 137500.0 250483 D This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant. /s/ Martin Dekker 2018-11-20